Target intelligence / Profile preview

Voltage-gated potassium and calcium channels (VGKC/VGCC)

Target
VGKC/VGCC
Molecular classification
Ion channel, Voltage-gated ion channel
01

Overview

Voltage-gated potassium (Kv) and calcium (Cav) channels are essential transmembrane proteins that respond to changes in membrane potential to regulate the flow of ions into and out of cells (StatPearls, 2023). Kv channels are primarily responsible for the repolarization phase of the action potential by allowing potassium efflux, thereby resetting the membrane potential (IUPHAR/BPS, 2023). Cav channels facilitate calcium influx in response to depolarization, serving as a vital link between electrical signals and intracellular physiological responses such as neurotransmission and muscle contraction (Catterall, 2011). These channels are fundamental to the proper functioning of the nervous and cardiovascular systems. Mutations or dysfunction in these proteins lead to various channelopathies, including cardiac arrhythmias and seizure disorders (PubMed, PMID: 28978322). Consequently, they are major therapeutic targets for antiarrhythmics, antihypertensives, and anticonvulsants (PubChem, 2024). This specific entry is flagged as incorrect because it combines two distinct and broad superfamilies of ion channels that should be evaluated as separate therapeutic targets.

Other names
Voltage-dependent potassium channelsVoltage-dependent calcium channelsVGKCsVGCCsK+ channelsCa2+ channels
02

Mechanism of action

Drugs targeting these channels typically act as pore blockers, preventing ion flow, or as gating modifiers that stabilize specific conformational states, such as the inactivated state, to modulate channel opening frequency and duration (StatPearls, 2023; IUPHAR/BPS, 2023).

03

Biological functions

Membrane potential regulationAction potential repolarizationNeurotransmitter releaseMuscle contractionSignal transductionCell excitability
04

Disease associations

EpilepsyCardiac arrhythmiaHypertensionChronic painLambert-Eaton myasthenic syndromeAtaxiaHypokalemic periodic paralysis
05

Safety considerations

Proarrhythmic effects (e.g., Torsades de Pointes)HypotensionPeripheral edemaDizzinessDrug-drug interactions due to CYP3A4 metabolism
06

Interacting drugs

Amiodarone

8 more in the full profile.

07

Biomarkers

QT interval (ECG)Serum calcium levelsElectroencephalogram (EEG) patternsMuscle strength tests

Beyond the preview

Go deeper on Voltage-gated potassium and calcium channels (VGKC/VGCC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated potassium and calcium channels (VGKC/VGCC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call